• Market movers: Alibaba, Broadcom, FuelCell Energy, OKYO Pharma... Proactive financial news Wed, 08 Jul 2026 14:30:00 GMT
• okyo pharma clears key fda milestone, advances toward phase 3 trial for neuropathic corneal pain Proactive financial news Wed, 08 Jul 2026 12:45:52 GMT
• OKYO Pharma advances urcosimod to Phase 3 trial for neuropathic corneal pain after positive FDA feedback Pluang Wed, 08 Jul 2026 12:43:27 GMT
• Okyo Pharma receives feedback from FDA Type D meeting on urcosimod pathway TipRanks Wed, 08 Jul 2026 12:01:33 GMT
• OKYO Pharma receives FDA feedback on phase 3 neuropathic pain trial Investing.com Wed, 08 Jul 2026 11:52:34 GMT
• OKYO Pharma Secures FDA Backing to Advance Urcosimod into Global Phase 3 Trial for Neuropathic Corneal Pain TipRanks Wed, 08 Jul 2026 11:33:37 GMT
• okyo pharma receives 'positive feedback' from fda meeting about phase 3 trial of urcosimod to treat neuropathic corneal pain marketscreener.com Wed, 08 Jul 2026 11:29:42 GMT
• OKYO Pharma (NASDAQ: OKYO) gets FDA feedback on pivotal Phase 3 NCP trial Stock Titan Wed, 08 Jul 2026 11:00:38 GMT
• FDA feedback pushes OKYO Pharma into Phase 3 eye-pain study Stock Titan Wed, 08 Jul 2026 11:00:00 GMT
• OKYO Pharma reports FDA feedback, advances urcosimod into Phase 3 trial for neuropathic corneal pain Proactive financial news Wed, 08 Jul 2026 08:33:00 GMT
• OKYO Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16] Moomoo Wed, 08 Jul 2026 00:50:21 GMT
• OKYO Pharma clears key FDA milestone, advances toward Phase 3 trial for Neuropathic corneal pain Yahoo Finance UK Tue, 07 Jul 2026 15:18:08 GMT
• OKYO Pharma to Highlight Neuropathic Corneal Pain Program at Piper Sandler Virtual Ophthalmology Symposium TipRanks Tue, 07 Jul 2026 11:37:01 GMT
• OKYO Pharma (OKYO) to join Piper Sandler 2026 Virtual Ophthalmology Symposium fireside chat Stock Titan Tue, 07 Jul 2026 11:00:43 GMT
• OKYO Pharma to Participate in a Fireside Chat at Piper Sandler 2026 Virtual Ophthalmology Symposium GlobeNewswire Tue, 07 Jul 2026 11:00:00 GMT
• OKYO Pharma CEO to speak at Piper Sandler virtual eye event July 9 Stock Titan Tue, 07 Jul 2026 11:00:00 GMT
• OKYO Pharma announces participation in Piper Sandler 2026 Virtual Ophthalmology Symposium Proactive financial news Tue, 07 Jul 2026 10:36:00 GMT
• Price to book forward of OKYO Pharma Limited – NASDAQ:OKYO TradingView Sun, 28 Jun 2026 03:59:45 GMT
• enterprise value to revenue forward of okyo pharma limited – nasdaq:okyo TradingView Sat, 27 Jun 2026 15:11:04 GMT
• okyo pharma ltd (okyo) earnings forecast: future eps & revenue growth estimates TradingKey Tue, 23 Jun 2026 07:00:00 GMT
• okyo pharma ltd (okyo) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 23 Jun 2026 07:00:00 GMT
• OKYO Pharma (OKYO) Edges Higher as Biotech Stock Tests Key Resistance Near $1.67 - Channel Breakout dars.gov.et Sat, 20 Jun 2026 07:00:00 GMT
• okyo pharma ltd (okyo) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 18:38:53 GMT
• okyo pharma ltd (okyo) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 18:35:29 GMT
• okyo pharma ltd (okyo) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 18:09:52 GMT
• okyo pharma ltd (okyo) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 21:40:54 GMT
• okyo pharma ltd (okyo) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 21:30:51 GMT
• okyo pharma ltd (okyo) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 21:18:50 GMT
• OKYO (NASDAQ: OKYO) CMO Mantelli reports multi-year option holdings in Form 3 Stock Titan Wed, 17 Jun 2026 07:00:00 GMT
• okyo pharma ltd (okyo) earnings forecast: future eps & revenue growth estimates TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• okyo pharma ltd (okyo) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• OKYO Pharma (OKYO) director awarded options on 3,500 common shares Stock Titan Wed, 10 Jun 2026 07:00:00 GMT
• okyo pharma (okyo) cfo receives grant of 40,000 options at $1.85 Stock Titan Wed, 10 Jun 2026 07:00:00 GMT
• okyo pharma (okyo) director awarded options for 6,500 shares at $1.85 Stock Titan Wed, 10 Jun 2026 07:00:00 GMT
• okyo pharma (okyo) director adds 300,000-share grant via panetta partners Stock Titan Wed, 10 Jun 2026 07:00:00 GMT
• director at okyo pharma (nasdaq: okyo) receives stock options on 6,500 shares Stock Titan Wed, 10 Jun 2026 07:00:00 GMT
• okyo pharma slips 1.85% as shares test key support level - trend following picks newsline.com Mon, 08 Jun 2026 16:35:11 GMT
• okyo pharma (okyo) retreats toward support as biotech sector faces headwinds - inverse etf flow newsline.com Sun, 07 Jun 2026 07:00:00 GMT
• okyo pharma (okyo) director reports detailed stock option grants Stock Titan Tue, 02 Jun 2026 07:00:00 GMT
• okyo pharma (okyo) director discloses stock and option holdings Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
• [form 3] okyo pharma ltd initial statement of beneficial ownership Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
• okyo pharma edges lower, holds steady near key support level - stop loss guidance newsline.com Sun, 31 May 2026 07:00:00 GMT
• okyo stock price, quote & chart | okyo pharma ltd (nasdaq:okyo) ChartMill Fri, 29 May 2026 07:00:00 GMT
• okyo pharma (okyo) edges higher on modest gains, holds above key support - sentiment divergence The Legal Advocate Thu, 28 May 2026 22:42:20 GMT
• okyo pharma shares edge higher as biotech momentum builds - spring pattern dars.gov.et Tue, 26 May 2026 07:00:00 GMT
• OKYO Pharma expands scientific advisory board with cornea expert - ICYMI Proactive financial news Sat, 23 May 2026 07:00:00 GMT
• okyo pharma (okyo) ceo discloses multiple stock option positions Stock Titan Fri, 22 May 2026 07:00:00 GMT
• okyo pharma ltd (okyo) cfo details equity and option positions Stock Titan Fri, 22 May 2026 07:00:00 GMT
• Okyo Pharma Appoints Marta Sacchetti, MD, Ph.D., to Scientific Advisory Board VisionMonday.com Wed, 20 May 2026 07:00:00 GMT
• okyo pharma adds marta sacchetti to scientific advisory board by investing.com Investing.com India Wed, 20 May 2026 00:04:17 GMT
• okyo pharma appoints dr. marta sacchetti, former head of clinical research at dompé farmaceutici, to scientific advisory board geneonline.com Tue, 19 May 2026 11:41:28 GMT
• okyo pharma limited expands scientific advisory board with appointment of marta sacchetti marketscreener.com Tue, 19 May 2026 11:00:00 GMT
• OKYO Expands Scientific Advisory Board with the Appointment of International Expert Marta Sacchetti, MD, PhD GlobeNewswire Tue, 19 May 2026 07:00:00 GMT
• okyo pharma adds marta sacchetti to scientific advisory board Investing.com Tue, 19 May 2026 07:00:00 GMT
• corneal disease expert marta sacchetti joins okyo’s fast track drug effort Stock Titan Tue, 19 May 2026 07:00:00 GMT
• okyo pharma appoints marta sacchetti to advisory board by investing.com Investing.com Canada Tue, 19 May 2026 07:00:00 GMT
• okyo pharma adds ophthalmology specialist marta sacchetti to scientific advisory board Proactive financial news Tue, 19 May 2026 07:00:00 GMT
• okyo pharma adds european eye disease expert to advisory board as urcosimod advances in neuropathic corneal pain TipRanks Tue, 19 May 2026 07:00:00 GMT
• form 6k okyo pharma for: 19 may by investing.com Investing.com India Tue, 19 May 2026 07:00:00 GMT
• okyo pharma strengthens scientific advisory board with marta sacchetti appointment Yahoo Finance Tue, 19 May 2026 07:00:00 GMT
• okyo pharma (okyo) deepens ncp program with new advisory board expert Stock Titan Tue, 19 May 2026 07:00:00 GMT
• press release: okyo expands scientific advisory board with the appointment of international expert marta sacchetti, md, phd Moomoo Tue, 19 May 2026 07:00:00 GMT
• point72 and steven a. cohen report 0% stake in okyo (nasdaq: okyo) Stock Titan Fri, 15 May 2026 07:00:00 GMT
• sirenia capital (okyo) files schedule 13g reporting 7.7% ownership Stock Titan Fri, 15 May 2026 07:00:00 GMT
• woodline partners reports 7.0% stake in okyo pharma (nasdaq: okyo) Stock Titan Fri, 15 May 2026 07:00:00 GMT
• number of shareholders of okyo pharma limited – nasdaq:okyo TradingView Mon, 11 May 2026 03:19:07 GMT
• okyo pharma stock rises after company outlines development pathway for neuropathic corneal pain drug MSN Thu, 30 Apr 2026 00:25:58 GMT
• OKYO Pharma to present at Eyecelerator, share urcosimod data at ARVO annual meeting Proactive financial news Wed, 29 Apr 2026 07:00:00 GMT
• OKYO CEO and CSO to Present and Leadership Team to Participate at Upcoming Scientific Conferences in May GlobeNewswire Wed, 29 Apr 2026 07:00:00 GMT
• denver eye meetings put okyo’s ceo and eye-pain drug study on stage Stock Titan Wed, 29 Apr 2026 07:00:00 GMT
• okyo pharma (nasdaq: okyo) showcases urcosimod ncp data at eyecelerator and arvo Stock Titan Wed, 29 Apr 2026 07:00:00 GMT
• okyo pharma to showcase urcosimod ncp data at may ophthalmology meetings in denver TipRanks Wed, 29 Apr 2026 07:00:00 GMT
• okyo pharma limited sponsored adr (nasdaq:okyo) short interest up 31.9% in april MarketBeat Wed, 29 Apr 2026 07:00:00 GMT
• okyo pharma limited sponsored adr (nasdaq:okyo) short interest down 25.0% in march MarketBeat Wed, 15 Apr 2026 22:44:38 GMT
• piper sandler maintains okyo pharma(okyo.us) with buy rating, maintains target price $7 富途牛牛 Tue, 14 Apr 2026 01:44:12 GMT
• aug action: how does okyo pharma limited compare to its peers baoquankhu1.vn Mon, 13 Apr 2026 08:23:30 GMT
• piper sandler maintains okyo pharma(okyo.us) with buy rating, maintains target price $7 Moomoo Mon, 13 Apr 2026 07:00:00 GMT
• okyo pharma limited sponsored adr (nasdaq:okyo) given average recommendation of "hold" by brokerages MarketBeat Sat, 11 Apr 2026 07:00:00 GMT
• aug sentiment: is okyo pharma limited a turnaround story - market risk report & weekly watchlist for hot stocks baoquankhu1.vn Thu, 09 Apr 2026 19:33:57 GMT
• gap down: can okyo pharma limited beat the s p 500 - 2026 chart watch & safe entry point alerts baoquankhu1.vn Thu, 09 Apr 2026 13:02:03 GMT
• market outlook: can okyo pharma limited beat the s p 500 - 2026 key lessons & long-term growth stock strategies baoquankhu1.vn Thu, 09 Apr 2026 12:58:41 GMT
• okyo pharma to hold advisory board meeting at ascrs conference by investing.com Investing.com Nigeria Thu, 09 Apr 2026 06:11:15 GMT
• what accelerates growth of okyo (okyo) stock | price at $1.58, down 0.94% - chaikin flow newsline.com Wed, 08 Apr 2026 07:00:00 GMT
• 9 health care stocks moving in wednesday's pre-market session Benzinga Wed, 08 Apr 2026 07:00:00 GMT
• okyo pharma advances clinical strategy with sab meeting and ascrs presentation Proactive financial news Tue, 07 Apr 2026 08:40:00 GMT
• OKYO Pharma Announces Scientific Advisory Board Meeting and Urcosimod Data Presentation During ASCRS Annual Meeting Yahoo Finance Tue, 07 Apr 2026 07:00:00 GMT
• OKYO Pharma to hold advisory board meeting at ASCRS conference Investing.com Tue, 07 Apr 2026 07:00:00 GMT
• Small cap wrap: Replenish Nutrients, OKYO Pharma, Bit Digital, Record Resources… Proactive financial news Tue, 07 Apr 2026 07:00:00 GMT
• eye pain drug data gets ascrs spotlight ahead of okyo's next trial Stock Titan Tue, 07 Apr 2026 07:00:00 GMT
• is okyo (okyo) stock in an uptrend | price at $1.60, up 1.91% - size factor The Legal Advocate Tue, 07 Apr 2026 07:00:00 GMT
• okyo pharma to hold scientific advisory board meeting at ascrs 2026 Proactive financial news Tue, 07 Apr 2026 07:00:00 GMT
• okyo pharma to showcase urcosimod data and convene key advisory board at 2026 ascrs meeting TipRanks Tue, 07 Apr 2026 07:00:00 GMT
• okyo pharma (okyo) showcases urcosimod phase 2 data and plans 150-patient trial Stock Titan Tue, 07 Apr 2026 07:00:00 GMT
• income plays: is okyo pharma limited stock trending bullish - portfolio profit report & free reliable trade execution plans baoquankhu1.vn Mon, 06 Apr 2026 15:38:44 GMT
• resistance check: what are okyo pharma limiteds growth levers - risk management & verified entry point detection baoquankhu1.vn Mon, 06 Apr 2026 14:12:59 GMT
• okyo sec filings - okyo pharma ltd 10-k, 10-q, 8-k forms Stock Titan Thu, 02 Apr 2026 04:19:12 GMT
• portfolio recap: what is okyo pharma limiteds revenue forecast - market rally & ai forecasted entry and exit points baoquankhu1.vn Sun, 29 Mar 2026 09:05:17 GMT
• okyo pharma limited sponsored adr (nasdaq:okyo) short interest update MarketBeat Fri, 27 Mar 2026 07:00:00 GMT
• how does okyo pharma limited compare to its peers - global markets & accurate buy signal notifications baoquankhu1.vn Thu, 26 Mar 2026 02:28:51 GMT
• okyo earnings history & surprises | eps & revenue results | okyo pharma ltd (nasdaq:okyo) ChartMill Tue, 24 Mar 2026 23:44:10 GMT
• OKYO reports improved quality of life outcomes with urcosimod in phase 2a NCP trial Ophthalmology Times Europe Fri, 20 Mar 2026 07:00:00 GMT
• okyo pharma chairman increases stake following positive neuropathic corneal pain trial The Globe and Mail Fri, 20 Mar 2026 07:00:00 GMT
• okyo earnings history & surprises | eps & revenue results | okyo pharma ltd (nasdaq:okyo) ChartMill Thu, 19 Mar 2026 22:17:47 GMT
• a director just increased his okyo pharma stake to 31,201 shares Stock Titan Thu, 19 Mar 2026 14:00:00 GMT
• okyo pharma officer acquires 30,980 shares at $1.59 by investing.com Investing.com Canada Thu, 19 Mar 2026 11:10:55 GMT
• OKYO Pharma Announces Chief Development Officer and Director Acquires Shares Yahoo Finance Thu, 19 Mar 2026 07:00:00 GMT
• okyo pharma announces chairman and founder acquires shares Yahoo Finance Thu, 19 Mar 2026 07:00:00 GMT
• okyo pharma reports positive quality-of-life findings for urcosimod in neuropathic corneal pain study Eyewire+ Thu, 19 Mar 2026 07:00:00 GMT
• okyo pharma executive chairman linked entity acquires additional shares on nasdaq Investing.com Thu, 19 Mar 2026 07:00:00 GMT
• okyo pharma executive chairman increases stake with share purchase Proactive financial news Thu, 19 Mar 2026 07:00:00 GMT
• okyo pharma (nasdaq: okyo) chair adds shares as ncp drug advances Stock Titan Thu, 19 Mar 2026 07:00:00 GMT
• okyo pharma director acquires 30,980 shares, increases total holding Investing.com Thu, 19 Mar 2026 07:00:00 GMT
• okyo pharma announces director stock purchase Proactive financial news Thu, 19 Mar 2026 07:00:00 GMT
• okyo pharma executive increases stake following positive urcosimod trial progress TipRanks Thu, 19 Mar 2026 07:00:00 GMT
• okyo pharma (nasdaq: okyo) director boosts stake with 5,000-share purchase Stock Titan Thu, 19 Mar 2026 07:00:00 GMT
• biotech executive buys more okyo stock, lifting stake to 108,920 shares Stock Titan Thu, 19 Mar 2026 07:00:00 GMT
• okyo pharma (nasdaq: okyo) cdo buys 30,980 shares at $1.59 Stock Titan Thu, 19 Mar 2026 07:00:00 GMT
• okyo pharma chairman increases stake following positive neuropathic corneal pain trial TipRanks Thu, 19 Mar 2026 07:00:00 GMT
• okyo pharma director boosts stake as lead eye-pain drug advances toward phase 2b/3 TipRanks Thu, 19 Mar 2026 07:00:00 GMT
• okyo pharma limited reports share acquisition by chief development officer and advances in neuropathic corneal pain therapy develo... Quiver Quantitative Thu, 19 Mar 2026 07:00:00 GMT
• okyo pharma director acquires additional shares on nasdaq Investing.com Thu, 19 Mar 2026 07:00:00 GMT
• okyo pharma reports improved quality-of-life outcomes in mid-stage eye pain trial Proactive financial news Thu, 19 Mar 2026 07:00:00 GMT
• okyo pharma reports quality of life improvements in pain trial by investing.com Investing.com Australia Thu, 19 Mar 2026 04:48:33 GMT
• okyo pharma reports results from phase 2a trial of urcosimod TipRanks Thu, 19 Mar 2026 02:35:13 GMT
• okyo pharma (okyo) chief development officer reports stock and option holdings Stock Titan Thu, 19 Mar 2026 01:07:33 GMT
• okyo pharma (okyo) director cerrone reports 10.5m common-share stake on form 3 Stock Titan Thu, 19 Mar 2026 01:07:32 GMT
• urcosimod phase 2 ncp data show qol gains, okyo pharma (okyo) plans phase 2b/3 Stock Titan Wed, 18 Mar 2026 11:58:21 GMT
OKYO Pharma(NASDAQ:OKYO) 
OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. It is developing OK-101 for the treatment of dry eye disease; and OK-201, a bovine adrenal medulla, lipidated-...
Website: https://www.okyopharma.com
Founded: 2007
IPO Price: $4 (May 17, 2022)
Full Time Employees: 6
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends